Tumor engineering: The other face of tissue engineering

Tissue Engineering - Part A

Volumn 16, Issue 7, 2010, Pages 2153-2156

  Ghajar, Cyrus M ^a   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMIMETICS; CELL CULTURE; MODELS; TUMORS;

BIOMIMETIC STRATEGY; IN-VIVO; LIFE SCIENTISTS; MICROENVIRONMENTS; MULTIPLE SCALE; TUMOR BIOLOGY; TUMOR DEVELOPMENT; TUMOR MICROENVIRONMENT;

TISSUE ENGINEERING;

SIGNAL PEPTIDE;

ANIMAL; ARTICLE; ECONOMICS; EXTRACELLULAR MATRIX; HEALTH CARE COST; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; TISSUE ENGINEERING;

ANIMALS; EXTRACELLULAR MATRIX; HEALTH CARE COSTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; TISSUE ENGINEERING;

EID: 77954518306     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0135     Document Type: Article

References (48)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. O'Connell, D., and Roblin, D. Translational research in the pharmaceutical industry: from bench to bedside. Drug Dis-cov Today 11, 833, 2006.
3. Sporn, M.B. The war on cancer. Lancet 347, 1377, 1996.
4. Rangarajan, A., and Weinberg, R.A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer 3, 952, 2003.
5. Nelson, C.M., and Bissell, M.J. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15, 342, 2005.
6. Fischbach-Teschl, C., and Stroock, A. Microfluidic culture models of tumor angiogenesis. Tissue Eng 2010. Epub ahead of print.
7. Verbridge, S., Chandler, E., and Fischbach-Teschl, C. Tissue-engineered 3-D tumor models to study tumor angiogenesis. Tissue Eng 2010. Epub ahead of print.
8. Yamada, K.M., and Cukierman, E. Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601, 2007.
9. Ronnov-Jessen, L., Petersen, O.W., and Bissell, M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76, 69, 1996.
10. Bissell, M.J. The differentiated state of normal and malignant cells or how to define a "normal'' cell in culture. Int Rev Cytol 70, 27, 1981.
11. Ronnov-Jessen, L., Petersen, O.W., Koteliansky, V.E., and Bissell, M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95, 859, 1995.
12. Bissell, M.J., and Radisky, D. Putting tumours in context. Nat Rev Cancer 1, 46, 2001.
13. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
14. Cleaver, O., and Melton, D.A. Endothelial signaling during development. Nat Med 9, 661, 2003.
15. Ghajar, C.M., Suresh, V., Peyton, S.R., Raub, C.B., Meyskens, F.L., Jr., George, S.C., and Putnam, A.J. A novel three-dimensional model to quantify metastatic melanoma invasion. Mol Cancer Ther 6, 552, 2007.
16. Kenny, P.A., Lee, G.Y., Myers, C.A., Neve, R.M., Semeiks, J.R., Spellman, P.T., Lorenz, K., Lee, E.H., Barcellos-Hoff, M.H., Petersen, O.W., Gray, J.W., and Bissell, M.J. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 1, 84, 2007.
17. Miller, B.E., Miller, F.R., and Heppner, G.H. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res 45, 4200, 1985.
18. Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R., and Bis-sell, M.J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89, 9064, 1992.
19. Weaver, V.M., Lelievre, S., Lakins, J.N., Chrenek, M.A., Jones, J.C., Giancotti, F., Werb, Z., and Bissell, M.J. Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205, 2002.
20. Derda, R., Laromaine, A., Mammoto, A., Tang, S.K., Mam-moto, T., Ingber, D.E., and Whitesides, G.M. Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci USA 106, 18457, 2009.
21. Petersen, O.W., Nielsen, H.L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M.J., and Ronnov-Jessen, L. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 162, 391, 2003.
22. Folkman, J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285, 1182, 1971.
23. Olumi, A.F., Grossfeld, G.D., Hayward, S.W., Carroll, P.R., Tlsty, T.D., and Cunha, G.R. Carcinoma-associated fibro-blasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59, 5002, 1999.
24. Chamras, H., Bagga, D., Elstner, E., Setoodeh, K., Koeffler, H.P., and Heber, D. Preadipocytes stimulate breast cancer cell growth. Nutr Cancer 32, 59, 1998.
25. Lin, E.Y., Li, J.F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D.A., Qian, H., Xue, X.N., and Pollard, J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66, 11238, 2006.
26. Nozawa, H., Chiu, C., and Hanahan, D. Infiltrating neutro-phils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103, 12493, 2006.
27. DeNardo, D.G., Barreto, J.B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., and Coussens, L.M. CD4(-+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16, 91, 2009.
28. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N.R., Crystal, R.G., Moore, M.A., Hajjar, K.A., Manova, K., Benezra, R., and Rafii, S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogene-sis and growth. Nat Med 7, 1194, 2001.
29. Spaeth, E.L., Dembinski, J.L., Sasser, A.K., Watson, K., Klopp, A., Hall, B., Andreeff, M., and Marini, F. Mesench-ymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 4, e4992, 2009.
30. Radisky, D., Hagios, C., and Bissell, M.J. Tumors are unique organs defined by abnormal signaling and context. Semin Cancer Biol 11, 87, 2001.
31. Bissell, M.J., Hall, H.G., and Parry, G. How does the extracellular matrix direct gene expression? J Theor Biol 99, 31, 1982.
32. Folkman, J. Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg 42, 1, 2007.
33. Jain, R.K. Normalizing tumor vasculature with anti-angio-genic therapy: a new paradigm for combination therapy. Nat Med 7, 987, 2001.
34. Ebos, J.M., Lee, C.R., Cruz-Munoz, W., Bjarnason, G.A., Christensen, J.G., and Kerbel, R.S. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15, 232, 2009.
35. Ellis, L.M., and Reardon, D.A. Cancer: the nuances of therapy. Nature 458, 290, 2009.
36. Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Bergers, G., Hanahan, D., and Casanovas, O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220, 2009.
37. Choi, N.W., Cabodi, M., Held, B., Gleghorn, J.P., Bonassar, L.J., and Stroock, A.D. Microfluidic scaffolds for tissue engineering. Nat Mater 6, 908, 2007.
38. Chrobak, K.M., Potter, D.R., and Tien, J. Formation of perfused, functional microvascular tubes in vitro. Microvasc Res 71, 185, 2006.
39. Nelson, C.M., Vanduijn, M.M., Inman, J.L., Fletcher, D.A., and Bissell, M.J. Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 314, 298, 2006.
40. LaBarge, M.A., Nelson, C.M., Villadsen, R., Fridriksdottir, A., Ruth, J.R., Stampfer, M.R., Petersen, O.W., and Bissell, M.J. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenviron-ments. Integr Biol (Camb) 1, 70, 2009.
41. Lutolf, M.P., and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23, 47, 2005.
42. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. Engineering tumors with 3D scaffolds. Nat Methods 4, 855, 2007.
43. Fischbach, C., Kong, H.J., Hsiong, S.X., Evangelista, M.B., Yuen, W., and Mooney, D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 106, 399, 2009.
44. Verbridge, S., Choi, N., Zheng, Y., Brooks, D., Stroock, A., and Fischbach-Teschl, C. Oxygen-controlled 3-D cultures to analyze tumor angiogenesis. Tissue Eng 2010. Epub ahead of print.
45. LaBarge, M.A., Ghajar, C.M., Pollock, J., Spencer, V.A., Healy, K., and Bissell, M.J. Use of synthetic matrices to identify domains of laminin-111 essential for crucial mammary functions. J Biol Chem (in revision) 2010.
46. Chen, A., Cuevas, I., Kenny, P.A., Miyake, H., Mace, K., Ghajar, C., Boudreau, A., Bissell, M., and Boudreau, N. En-dothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Res 69, 6721, 2009.
47. Dvorak, H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315, 1650, 1986.
48. Sieweke, M.H., Thompson, N.L., Sporn, M.B., and Bissell, M.J. Mediation of wound-related Rous sarcoma virus tu-morigenesis by TGF-beta. Science 248, 1656, 1990.